Pavmed Series Z Stock Market Value
PAVMZ Stock | USD 0.01 0.0001 0.66% |
Symbol | PAVmed |
PAVmed Series Z Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed Series. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed Series listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.459 | Quarterly Revenue Growth 4.898 | Return On Assets (0.80) | Return On Equity (13.58) |
The market value of PAVmed Series Z is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed Series' value that differs from its market value or its book value, called intrinsic value, which is PAVmed Series' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed Series' market value can be influenced by many factors that don't directly affect PAVmed Series' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PAVmed Series' value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed Series is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed Series' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
PAVmed Series 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PAVmed Series' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PAVmed Series.
10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in PAVmed Series on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding PAVmed Series Z or generate 0.0% return on investment in PAVmed Series over 30 days. PAVmed Series is related to or competes with Vestis, Emerson Radio, Fevertree Drinks, Herc Holdings, Canlan Ice, and Willscot Mobile. PAVmed Series is entity of United States More
PAVmed Series Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PAVmed Series' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PAVmed Series Z upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 44.96 | |||
Information Ratio | 0.1906 | |||
Maximum Drawdown | 292.58 | |||
Value At Risk | (55.87) | |||
Potential Upside | 99.33 |
PAVmed Series Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for PAVmed Series' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PAVmed Series' standard deviation. In reality, there are many statistical measures that can use PAVmed Series historical prices to predict the future PAVmed Series' volatility.Risk Adjusted Performance | 0.1574 | |||
Jensen Alpha | 11.23 | |||
Total Risk Alpha | 1.89 | |||
Sortino Ratio | 0.227 | |||
Treynor Ratio | (1.37) |
PAVmed Series Z Backtested Returns
PAVmed Series is out of control given 3 months investment horizon. PAVmed Series Z maintains Sharpe Ratio (i.e., Efficiency) of 0.26, which implies the company had a 0.26% return per unit of standard deviation over the last 3 months. We have collected data for thirty different technical indicators, which can help you to evaluate if expected returns of 50.46% are justified by taking the suggested risk. Use PAVmed Series Market Risk Adjusted Performance of (1.36), coefficient of variation of 518.1, and Mean Deviation of 37.45 to evaluate company specific risk that cannot be diversified away. PAVmed Series holds a performance score of 20 on a scale of zero to a hundred. The firm holds a Beta of -7.54, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning PAVmed Series are expected to decrease by larger amounts. On the other hand, during market turmoil, PAVmed Series is expected to outperform it. Use PAVmed Series semi variance, as well as the relationship between the rate of daily change and relative strength index , to analyze future returns on PAVmed Series.
Auto-correlation | -0.18 |
Insignificant reverse predictability
PAVmed Series Z has insignificant reverse predictability. Overlapping area represents the amount of predictability between PAVmed Series time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PAVmed Series Z price movement. The serial correlation of -0.18 indicates that over 18.0% of current PAVmed Series price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.18 | |
Spearman Rank Test | 0.1 | |
Residual Average | 0.0 | |
Price Variance | 0.0 |
PAVmed Series Z lagged returns against current returns
Autocorrelation, which is PAVmed Series stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting PAVmed Series' stock expected returns. We can calculate the autocorrelation of PAVmed Series returns to help us make a trade decision. For example, suppose you find that PAVmed Series has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
PAVmed Series regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If PAVmed Series stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if PAVmed Series stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in PAVmed Series stock over time.
Current vs Lagged Prices |
Timeline |
PAVmed Series Lagged Returns
When evaluating PAVmed Series' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of PAVmed Series stock have on its future price. PAVmed Series autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, PAVmed Series autocorrelation shows the relationship between PAVmed Series stock current value and its past values and can show if there is a momentum factor associated with investing in PAVmed Series Z.
Regressed Prices |
Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for PAVmed Stock Analysis
When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.